跳至主要内容
临床试验/TCTR20170206005
TCTR20170206005Enrolling By Invitation未知

Effect of diltiazem on tacrolimus concentration in CYP3A5 expressers Thai kidney transplant recipients

Chulalongkorn University0 个研究点目标入组 140 人开始时间: 2017年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. First kidney transplantation
  • 2. Living related kidney transplant patients
  • 3. Being prescribed mycophenolate mofetil or mycophenate sodium, tacrolimus and prednisolone as maintenance immunosuppressive agent to prevent allograft rejection

排除标准

  • 1. more than one organ transplantation
  • 2. ABO incompatible transplantation
  • 3. patients who require anti-thymocyte immunoglobulin for induction therapy
  • 4. patients who receive concomitant drugs (other than methylprednisolone, prednisolone and omeprazole) that may affect CYP3A4 and P-glycoprotein activity
  • 5. patients with history of cirrhosis, elevated liver enzyme more than 3x of upper limit normal (AST>100 U/L and ALT>120 U/L) or hepatitis C viral infection
  • 6. active gastrointestinal disorder
  • 7. anemia (Hb<9 g/dL)
  • 8. hypoalbuminemia (Alb<3 g/dL)
  • 9. blood preesure below 110/70 mmHg
  • 10. fever or active infection
  • 11. incomplete data in medication record and/or computer system

研究者

相似试验

Effect of diltiazem and CYP3A5 genetic polymorphism... | 临床试验